Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Natalie Duerkopp"'
Autor:
William S DeWitt, Paul Lindau, Thomas M Snyder, Anna M Sherwood, Marissa Vignali, Christopher S Carlson, Philip D Greenberg, Natalie Duerkopp, Ryan O Emerson, Harlan S Robins
Publikováno v:
PLoS ONE, Vol 11, Iss 8, p e0160853 (2016)
The vast diversity of B-cell receptors (BCR) and secreted antibodies enables the recognition of, and response to, a wide range of epitopes, but this diversity has also limited our understanding of humoral immunity. We present a public database of mor
Externí odkaz:
https://doaj.org/article/1920199887e44a0792c0ea7d7902df16
Autor:
Valentin Voillet, Megan S. McAfee, Kelly G. Paulson, M. Juliana McElrath, Hieu Nguyen, Raphael Gottardo, Ted Gooley, Aude G. Chapuis, Cecilia C. Yeung, Aaron Seese, Natalie Duerkopp, Petri Muhlhauser, Daniel Hunter, Philip D. Greenberg, Daniel N. Egan, Gunnar B. Ragnarsson, Felecia Wagener, Marcus Lindberg, Kristen W. Cohen, Luca Castelli, Merav Bar, Lara Kropp, Marie Bleakley, Thomas M. Schmitt
Publikováno v:
Nature Medicine. 25:1064-1072
Relapse after allogeneic hematopoietic cell transplantation (HCT) is the leading cause of death in patients with acute myeloid leukemia (AML) entering HCT with poor-risk features1–3. When HCT does produce prolonged relapse-free survival, it commonl
Autor:
Phil Greenberg, Natalie Duerkopp, Cecilia Yeung, Daniel Hunter, Aude G. Chapuis, Sylvia Lee, Kieu-Thu Bui, Felecia Wagener, Bernardo H. L. Goulart, Maurizio Perdicchio, Judy Delismon, Thomas M. Schmitt, Megan S. McAfee, Hieu Nguyen
Publikováno v:
Journal of Thoracic Oncology. 12:S1384-S1385
Autor:
Philip Hezel, Philipp Niemeyer, Roland Bosse, Ulf Krause, Natalie Duerkopp, Matthias Siepe, Christian Schlensak, Friedhelm Beyersdorf, Norbert P. Südkamp, Andreas R. Thomsen, Katharina Förster
Publikováno v:
Tissue Engineering Part A. 15:1787-1796
Mesenchymal stromal cells represent an attractive cell population for cell transplantation and tissue engineering purposes. The aim of this study was to search for neonatal thymus-derived mesenchymal stromal cells (nTMSC) and further characterize the
Autor:
Aude G. Chapuis, Luca Castelli, Felecia Wagener, Maurizio Perdicchio, Daniel Egan, Philip D. Greenberg, Daniel Hunter, M J McElrath, Thomas M. Schmitt, Megan S. McAfee, Aaron Seese, Hieu Nguyen, Lara Kropp, Cecilia C. S. Yeung, Natalie Duerkopp, Kieu-Thu Bui, Merav Bar, Kristen W. Cohen, Gunnar B. Ragnarsson, Deborah E. Banker
Publikováno v:
Blood. 128:1001-1001
Leukemic relapse after allogeneic hematopoietic cell transplantation (HCT) remains a major cause of treatment failure in patients (pts) who enter HCT with high-risk acute myeloid leukemia (AML). Therapeutic "graft-versus-leukemia" (GVL) effects are o
Autor:
Philip D. Greenberg, Anna Sherwood, Thomas M. Snyder, Harlan Robins, William S DeWitt, Marissa Vignali, Christopher S. Carlson, Paul Lindau, Ryan O. Emerson, Natalie Duerkopp
Publikováno v:
PLoS ONE
PLoS ONE, Vol 11, Iss 8, p e0160853 (2016)
PLoS ONE, Vol 11, Iss 8, p e0160853 (2016)
The vast diversity of B-cell receptors (BCR) and secreted antibodies enables the recognition of, and response to, a wide range of epitopes, but this diversity has also limited our understanding of humoral immunity. We present a public database of mor
Autor:
Philip D. Greenberg, Felecia Wagener, Mark F Tom, Aude G. Chapuis, Thomas M. Schmitt, Kieu-Thu Bui, Merav Bar, Colette Chaney, Natalie Duerkopp, Hieu Nguyen, Shelly Heimfeld
Publikováno v:
Blood. 124:3939-3939
Relapse is the leading cause of death following allogeneic hematopoietic cell transplant (HCT) for high risk acute myeloid leukemia (AML). Antigen-specific T cells that selectively target leukemia associated antigen (LAA) have the potential to promot
Autor:
Ilana M. Roberts, Galina Pogosov, Jeff Pufnock, William Y. Ho, Colette Chaney, Hieu Nguyen, Natalie Duerkopp, Gunnar B. Ragnarsson, Philip D. Greenberg, Cassian Yee, Aude G. Chapuis, Jerald P. Radich, Merav Bar, Tomas Schmitt
Publikováno v:
Blood. 120:350-350
Abstract 350 Relapse is the leading cause of death following allogeneic hematopoietic cell transplant (HCT) for hematological malignancies. Although evidence suggests that the beneficial donor T cell-mediated graft versus leukemia (GVL) effect can re